Tapewire

Nasdaq · USD

BMRN

BIOMARIN PHARMACEUTICAL INC

Export transactions ↓
Tapewire entity
2404
SEC CIK
0001048477
Parsed reports
685

Last 12 months

Inside the activity.

0 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202601
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 27, 2024 Filed Feb 29, 2024 22:16 UTC
Davis George EricEVP, Chief Legal Officer
GrantCommon Stock 6,284 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000026 · wk-form4_1709244996.xml · nonDerivative · entry 3

Davis George Eric · CIK 0001380710 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,897

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F3 · acquired: Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events.

F5 · acquired: Represents the total number of RSUs earned pursuant to a formula based on non-GAAP income over three, one-year periods spanning 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 22:16 UTC
Davis George EricEVP, Chief Legal Officer
GrantCommon Stock 9,063 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000026 · wk-form4_1709244996.xml · nonDerivative · entry 2

Davis George Eric · CIK 0001380710 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,613

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F3 · acquired: Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events.

F4 · acquired: Represents the total number of RSUs earned pursuant to a formula based on the number and nature of strategic goals achieved during 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 22:16 UTC
Davis George EricEVP, Chief Legal Officer
GrantCommon Stock 20,840 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000026 · wk-form4_1709244996.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,550

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · acquired: Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.

F3 · acquired: Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 22:14 UTC
Guyer Charles GregEVP, Chief Technical Officer
GrantCommon Stock 6,284 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000024 · wk-form4_1709244839.xml · nonDerivative · entry 3

Guyer Charles Greg · CIK 0001811096 · EVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,201

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events.

F5 · shares: Represents the total number of RSUs earned pursuant to a formula based on non-GAAP income over three, one-year periods spanning 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 22:14 UTC
Guyer Charles GregEVP, Chief Technical Officer
GrantCommon Stock 9,063 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000024 · wk-form4_1709244839.xml · nonDerivative · entry 2

Guyer Charles Greg · CIK 0001811096 · EVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,917

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events.

F4 · shares: Represents the total number of RSUs earned pursuant to a formula based on the number and nature of strategic goals achieved during 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 22:14 UTC
Guyer Charles GregEVP, Chief Technical Officer
GrantCommon Stock 20,840 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000024 · wk-form4_1709244839.xml · nonDerivative · entry 1

Guyer Charles Greg · CIK 0001811096 · EVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,854

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 22:12 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
GrantCommon Stock 6,465 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000022 · wk-form4_1709244737.xml · nonDerivative · entry 3

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,047

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events.

F5 · shares: Represents the total number of RSUs earned pursuant to a formula based on non-GAAP income over three, one-year periods spanning 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 22:12 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
GrantCommon Stock 9,338 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000022 · wk-form4_1709244737.xml · nonDerivative · entry 2

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,582

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events.

F4 · shares: Represents the total number of RSUs earned pursuant to a formula based on the number and nature of strategic goals achieved during 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 22:12 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
GrantCommon Stock 21,440 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000022 · wk-form4_1709244737.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,244

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 22:10 UTC
FUCHS HENRY JPresident, Worldwide R&D
GrantCommon Stock 9,238 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000020 · wk-form4_1709244617.xml · nonDerivative · entry 3

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 247,458

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events.

F5 · shares: Represents the total number of RSUs earned pursuant to a formula based on non-GAAP income over three, one-year periods spanning 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 22:10 UTC
FUCHS HENRY JPresident, Worldwide R&D
GrantCommon Stock 13,326 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000020 · wk-form4_1709244617.xml · nonDerivative · entry 2

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 238,220

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events.

F4 · shares: Represents the total number of RSUs earned pursuant to a formula based on the number and nature of strategic goals achieved during 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 22:10 UTC
FUCHS HENRY JPresident, Worldwide R&D
GrantCommon Stock 30,640 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000020 · wk-form4_1709244617.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 224,894

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 22:05 UTC SaleCommon Stock 1,000 $90.35 $90,350.00
Disclosure

SEC source: 0001048477-24-000018 · wk-form4_1709244306.xml · nonDerivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 562,203

Read SEC document
February 27, 2024 Filed Feb 29, 2024 22:05 UTC GrantCommon Stock 24,926 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000018 · wk-form4_1709244306.xml · nonDerivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 563,203

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events.

F5 · shares: Represents the total number of RSUs earned pursuant to a formula based on non-GAAP income over three, one-year periods spanning 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 22:05 UTC GrantCommon Stock 35,975 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000018 · wk-form4_1709244306.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 538,277

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events.

F4 · shares: Represents the total number of RSUs earned pursuant to a formula based on the number and nature of strategic goals achieved during 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 22:05 UTC GrantCommon Stock 82,700 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000018 · wk-form4_1709244306.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 502,302

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events.

Read SEC document
February 09, 2024 Filed Feb 12, 2024 22:20 UTC Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative 15,000 $0.00 Strike: $63.10 $0.00
Disclosure

SEC source: 0001048477-24-000010 · wk-form4_1707776385.xml · derivative · entry 10

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 131,000

Underlying: Common Stock · 15,000 shares

Expires 2024-06-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
February 09, 2024 Filed Feb 12, 2024 22:20 UTC SaleCommon Stock 15,000 $88.28 $1,324,200.00
Disclosure

SEC source: 0001048477-24-000010 · wk-form4_1707776385.xml · nonDerivative · entry 5

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 419,602

F3 · date: Trade made pursuant to a 10b5-1 plan executed on August 7, 2023.

Read SEC document
February 09, 2024 Filed Feb 12, 2024 22:20 UTC Exercise / conversionCommon Stock 15,000 $63.10 $946,500.00
Disclosure

SEC source: 0001048477-24-000010 · wk-form4_1707776385.xml · nonDerivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 434,602

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · date: Trade made pursuant to a 10b5-1 plan executed on August 7, 2023.

Read SEC document
February 08, 2024 Filed Feb 12, 2024 22:20 UTC Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative 15,000 $0.00 Strike: $63.10 $0.00
Disclosure

SEC source: 0001048477-24-000010 · wk-form4_1707776385.xml · derivative · entry 9

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 146,000

Underlying: Common Stock · 15,000 shares

Expires 2024-06-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
February 08, 2024 Filed Feb 12, 2024 22:20 UTC SaleCommon Stock 15,000 $89.77 $1,346,550.00
Disclosure

SEC source: 0001048477-24-000010 · wk-form4_1707776385.xml · nonDerivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 419,602

F3 · date: Trade made pursuant to a 10b5-1 plan executed on August 7, 2023.

Read SEC document
February 08, 2024 Filed Feb 12, 2024 22:20 UTC Exercise / conversionCommon Stock 15,000 $63.10 $946,500.00
Disclosure

SEC source: 0001048477-24-000010 · wk-form4_1707776385.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 434,602

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · date: Trade made pursuant to a 10b5-1 plan executed on August 7, 2023.

Read SEC document
January 18, 2024 Filed Feb 12, 2024 22:20 UTC OtherCommon Stock 40 $92.60 $3,703.90
Disclosure

SEC source: 0001048477-24-000010 · wk-form4_1707776385.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 419,602

F1 · date: The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 40 shares, with the reporting person's sale of shares at a price of $98.19 on January 9, 2024. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.

F2 · price: The price in column 4 is the weighted average price. The purchase price actually paid ranged from $92.595 to $92.60. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
January 10, 2024 Filed Jan 11, 2024 19:40 UTC Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative 10,000 $0.00 Strike: $63.10 $0.00
Disclosure

SEC source: 0001048477-24-000002 · wk-form4_1705002030.xml · derivative · entry 10

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 161,000

Underlying: Common Stock · 10,000 shares

Expires 2024-06-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
January 10, 2024 Filed Jan 11, 2024 19:40 UTC SaleCommon Stock 10,000 $96.38 $963,800.00
Disclosure

SEC source: 0001048477-24-000002 · wk-form4_1705002030.xml · nonDerivative · entry 5

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 425,162

F2 · date: Trade made pursuant to a 10b5-1 plan executed on August 7, 2023.

Read SEC document
January 10, 2024 Filed Jan 11, 2024 19:40 UTC Exercise / conversionCommon Stock 10,000 $63.10 $631,000.00
Disclosure

SEC source: 0001048477-24-000002 · wk-form4_1705002030.xml · nonDerivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 435,162

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on August 7, 2023.

Read SEC document
January 09, 2024 Filed Jan 11, 2024 19:40 UTC Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative 10,000 $0.00 Strike: $63.10 $0.00
Disclosure

SEC source: 0001048477-24-000002 · wk-form4_1705002030.xml · derivative · entry 9

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 171,000

Underlying: Common Stock · 10,000 shares

Expires 2024-06-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
January 09, 2024 Filed Jan 11, 2024 19:40 UTC SaleCommon Stock 10,000 $98.19 $981,900.00
Disclosure

SEC source: 0001048477-24-000002 · wk-form4_1705002030.xml · nonDerivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 425,162

F2 · date: Trade made pursuant to a 10b5-1 plan executed on August 7, 2023.

Read SEC document
January 09, 2024 Filed Jan 11, 2024 19:40 UTC Exercise / conversionCommon Stock 10,000 $63.10 $631,000.00
Disclosure

SEC source: 0001048477-24-000002 · wk-form4_1705002030.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 435,162

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on August 7, 2023.

Read SEC document
January 08, 2024 Filed Jan 11, 2024 19:40 UTC OtherCommon Stock 50 $99.05 $4,952.59
Disclosure

SEC source: 0001048477-24-000002 · wk-form4_1705002030.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 425,162

F1 · date: The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 50 shares, with the reporting person's sale of shares at a price of $98.19 on January 9, 2024. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.

Read SEC document
January 08, 2024 Filed Jan 24, 2024 00:47 UTC GiftCommon Stock 3,000 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000004 · wk-form4_1706057221.xml · nonDerivative · entry 1

MEIER RICHARD A · CIK 0001227305 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,547

Read SEC document
December 27, 2023 Filed Dec 28, 2023 18:18 UTC GrantCommon Stock 2,180 $0.00 $0.00
Disclosure

SEC source: 0001048477-23-000076 · wk-form4_1703787510.xml · nonDerivative · entry 1

Bodem Barbara W. · CIK 0001713893 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,180

F1 · price: Restricted stock units granted on December 27, 2023. Price not applicable.

Read SEC document
December 27, 2023 Filed Dec 28, 2023 18:13 UTC GrantCommon Stock 2,180 $0.00 $0.00
Disclosure

SEC source: 0001048477-23-000072 · wk-form4_1703787170.xml · nonDerivative · entry 1

Enyedy Mark J · CIK 0001586965 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,180

F1 · price: Restricted stock units granted on December 27, 2023. Price not applicable.

Read SEC document
December 27, 2023 Filed Dec 28, 2023 18:03 UTC GrantCommon Stock 2,180 $0.00 $0.00
Disclosure

SEC source: 0001048477-23-000068 · wk-form4_1703786629.xml · nonDerivative · entry 1

Countouriotis Athena · CIK 0001571469 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,180

F1 · price: Restricted stock units granted on December 27, 2023. Price not applicable.

Read SEC document
December 21, 2023 Filed Dec 22, 2023 22:14 UTC Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative 10,000 $0.00 Strike: $63.10 $0.00
Disclosure

SEC source: 0001048477-23-000064 · wk-form4_1703283254.xml · derivative · entry 6

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 181,000

Underlying: Common Stock · 10,000 shares

Expires 2024-06-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
December 21, 2023 Filed Dec 22, 2023 22:14 UTC SaleCommon Stock 10,000 $93.99 $939,900.00
Disclosure

SEC source: 0001048477-23-000064 · wk-form4_1703283254.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 425,112

F1 · date: Trade made pursuant to a 10b5-1 plan executed on August 7, 2023.

Read SEC document
December 21, 2023 Filed Dec 22, 2023 22:14 UTC Exercise / conversionCommon Stock 10,000 $63.10 $631,000.00
Disclosure

SEC source: 0001048477-23-000064 · wk-form4_1703283254.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 435,112

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on August 7, 2023.

Read SEC document
December 13, 2023 Filed Dec 14, 2023 23:18 UTC
Davis George EricEVP, Chief Legal Officer
SaleCommon Stock 13,764 $95.30 $1,311,709.20
Disclosure

SEC source: 0001048477-23-000059 · wk-form4_1702595890.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 55,710

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 13, 2023.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 22:13 UTC
Hardy AlexanderDirector · Chief Executive Officer
GrantStock Option (Right to Buy Common Stock) · Derivative 150,529 $0.00 Strike: $92.42 $0.00
Disclosure

SEC source: 0001048477-23-000055 · wk-form4_1701814423.xml · derivative · entry 3

Hardy Alexander · CIK 0002001910 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,529

Underlying: Common Stock · 150,529 shares

Expires 2033-11-30

F2 · derivative.exercise_date: Option grant vests 12/48th on December 1, 2024 and 1/48th on the 1st day of each month thereafter.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 22:13 UTC
Hardy AlexanderDirector · Chief Executive Officer
GrantCommon Stock 47,332 $0.00 $0.00
Disclosure

SEC source: 0001048477-23-000055 · wk-form4_1701814423.xml · nonDerivative · entry 2

Hardy Alexander · CIK 0002001910 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,371

F1 · price: Restricted stock units granted on December 1, 2023. Price not applicable.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 22:13 UTC
Hardy AlexanderDirector · Chief Executive Officer
GrantCommon Stock 68,039 $0.00 $0.00
Disclosure

SEC source: 0001048477-23-000055 · wk-form4_1701814423.xml · nonDerivative · entry 1

Hardy Alexander · CIK 0002001910 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,039

F1 · price: Restricted stock units granted on December 1, 2023. Price not applicable.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 21:59 UTC
Guyer Charles GregEVP, Chief Technical Officer
GrantCommon Stock 11,840 $0.00 $0.00
Disclosure

SEC source: 0001048477-23-000051 · wk-form4_1701813536.xml · nonDerivative · entry 2

Guyer Charles Greg · CIK 0001811096 · EVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,014

F2 · price: Restricted stock units granted on December 1, 2023. Price not applicable.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 21:56 UTC
FUCHS HENRY JPresident, Worldwide R&D
GrantCommon Stock 17,750 $0.00 $0.00
Disclosure

SEC source: 0001048477-23-000049 · wk-form4_1701813402.xml · nonDerivative · entry 2

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,254

F2 · price: Restricted stock units granted on December 1, 2023. Price not applicable.

Read SEC document
December 01, 2023 Filed Dec 13, 2023 00:55 UTC GrantCommon Stock 2,370 $0.00 $0.00
Disclosure

SEC source: 0001048477-23-000057 · wk-form4_1702428903.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 425,112

F2 · price: Restricted stock units granted on December 1, 2023. Price not applicable.

Read SEC document
October 31, 2023 Filed Dec 5, 2023 21:59 UTC
Guyer Charles GregEVP, Chief Technical Officer
GrantCommon Stock 133 $69.23 $9,207.99
Disclosure

SEC source: 0001048477-23-000051 · wk-form4_1701813536.xml · nonDerivative · entry 1

Guyer Charles Greg · CIK 0001811096 · EVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,174

F1 · date: Represents the shares acquired by the reporting person on October 31, 2023, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
October 04, 2023 Filed Dec 13, 2023 00:55 UTC OtherCommon Stock 10 $85.57 $855.66
Disclosure

SEC source: 0001048477-23-000057 · wk-form4_1702428903.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 422,742

F1 · date: The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 10 shares, with the reporting person's sale of shares at a price of $99.56 on April 10, 2023. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.

Read SEC document
August 16, 2023 Filed Aug 17, 2023 19:57 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
SaleCommon Stock 5,000 $90.00 $450,000.00
Disclosure

SEC source: 0001048477-23-000039 · wk-form4_1692302235.xml · nonDerivative · entry 2

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,804

F2 · date: Trade made pursuant to a 10b5-1 plan executed on April 13, 2023.

Read SEC document
August 10, 2023 Filed Aug 11, 2023 17:59 UTC
FUCHS HENRY JPresident, Worldwide R&D
SaleCommon Stock 12,000 $90.43 $1,085,110.80
Disclosure

SEC source: 0001048477-23-000037 · wk-form4_1691776761.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 176,187

F1 · price: The price in column 4 is the weighted average price. The price actually received ranged from $90.40 to $90.515. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
August 09, 2023 Filed Aug 10, 2023 20:47 UTC
Guyer Charles GregEVP, Chief Technical Officer
SaleCommon Stock 5,360 $93.30 $500,109.44
Disclosure

SEC source: 0001048477-23-000035 · wk-form4_1691700467.xml · nonDerivative · entry 1

Guyer Charles Greg · CIK 0001811096 · EVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,041

Read SEC document
August 08, 2023 Filed Aug 9, 2023 23:08 UTC
Davis George EricEVP, Chief Legal Officer
SaleCommon Stock 11,000 $89.42 $983,661.80
Disclosure

SEC source: 0001048477-23-000033 · wk-form4_1691622498.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,474

F1 · price: The price in column 4 is the weighted average price. The price actually received ranged from $89.39 to $89.52. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.